By Rachel Leeson
Read More
Addgene is excited to announce the launch of our partnership with the Institute for Protein Innovation (IPI). Together, we’ll be working to provide researchers with a collection of IPI’s well-validated and ready-to-use recombinant antibodies. The first collection, a set of ...
Last summer, we posted about our bioinformatics quest, which led us to Seqera Labs, a company that provides open source workflow orchestration software for data pipeline processing (Nextflow), cloud infrastructure, and secure collaboration.
We're excited to roll out the redesigned, revamped, and re-launched Addgene AAV Data Hub, the place for scientists to share their AAV validation data. The Data Hub contains a curated collection of community submissions for Addgene and CLOVER AAV experiments - and we've updated ...
We’re making some moves over here at Addgene...and they’re looping?
We are excited to announce the recipients of this year’s Michael Davidson and Roger Tsien Commemorative Conference Awards. Congratulations to the five winners!
We’re happy to introduce the newest member on Addgene’s Board of Directors, Bart Newland. Newland is General Counsel at Atalanta, an early-stage biotech company that is developing RNAi therapeutics to treat neurodegenerative diseases. He has earned a B.S. in microbiology and ...
Would you buy and use a plasmid if it didn’t include any plasmid sequence data? Of course not. Unfortunately, the vast majority of antibodies are supplied with no sequence information, leading to problems with reproducibility and an inability to improve upon these critical ...
